Imricor Medical Systems announced today the enrollment of the first patients in a clinical study to evaluate the Vision-MR Ablation Catheter for the treatment of atrial flutter under real-time MRI guidance. The study is sponsored by the Leipzig Heart Center in Leipzig, Germany. Professor Gerhard Hindricks MD, Head of the Department of Electrophysiology at the heart center, is the principal investigator. This single-center study will enroll up to 35 patients.
Imricor Medical Systems announced today that it has received CE mark for its Advantage-MR™ EP Recorder/Stimulator System; a first-of-its-kind MR Conditional recording system for MRI-guided electrophysiology (EP) procedures. The Advantage-MR system, along with Imricor’s Vision-MR™ Ablation Catheter, allows physicians to perform cardiac ablations under real-time MRI guidance with the potential to improve outcomes and provide safer, more cost-effective treatment – all in an environment that is free of radiation for both the patient and physician.
Imricor Medical Systems announced the dedication of Europe’s latest interventional MRI suite for electrophysiology (EP) procedures in Leipzig, Germany. With this state-of-the-art lab, Prof. Gerhard Hindricks MD, PhD and his team of physicians at the Heart Center in Leipzig will be able to perform cardiac ablations under real-time MRI guidance using Imricor’s unique MR compatible catheters and EP devices.
At the 2015 Heart Rhythm Society Scientific Sessions in Boston, MA, attendees gathered to learn how Imricor is making MRI-guided cardiac ablations a clinical reality. Physicians from around the world visited the Imricor booth to learn more about bringing Imricor’s innovative technology to their patients and institutions. Christopher Piorkowski MD, PhD (Head of the Department of Electrophysiology, University of Dresden Heart Center) spoke to a crowd of physicians and industry experts at the Imricor booth on Thursday, May 14 about his clinical experience with MRI-guided ablations and the future of interventional MRI EP procedures. Regarding MRI-guided ablations, Piorkowski said, “All of this has beautifully matured over the years. We have been able to bring this forward into actual human clinical medicine.”
The American Heart Association Advancing Sciences Breakfast selected Imricor Medical Systems as a finalist for its Twin Cities Innovation Grant Challenge; a competition for Minnesota-based med-tech companies with technology related to preventing or managing heart disease and stroke. The AHA Advancing Sciences Breakfast fosters dialogue and discovery among local business, med-tech, and life science leaders who can affect change in the fight against heart disease.